Beyond Air to Participate in the 38th Annual Roth Conference in March
Beyond Air (NASDAQ: XAIR) announced that CEO Steve Lisi will participate in the 38th Annual Roth Conference in Laguna Niguel, CA, March 22–24, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Beyond Air (NASDAQ: XAIR) announced that CEO Steve Lisi will participate in the 38th Annual Roth Conference in Laguna Niguel, CA, March 22–24, 2026.
Steve Lisi will appear for a fireside chat and one-on-one meetings on Monday, March 23 at 8:00am PT. A live webcast is available and an archive will be posted for 90 days after the event. Investors seeking a one-on-one should contact their bank representative to request a meeting.
Details
News Market Reaction – XAIR
On Mar 11, the day this news came out, XAIR closed 2.57% below the previous close.
Data tracked by StockTitan Argus for the Mar 11 session.
Key Figures
- Conference edition
- 38th Annual
- 38th Annual Roth Conference
- Conference dates
- March 22–24, 2026
- Roth Conference schedule
- Presentation time
- March 23, 8:00am PT
- Beyond Air fireside chat
- Webcast archive
- 90 days
- Webcast available on company website
Historical Context
-
Termination of proposed NeuroNOS sale after LOI expiration without definitive deal.
-
Company highlighted independent review of 27 high‑dose nitric oxide studies.
-
Reported Q3 2026 results with 105% YoY revenue growth and maintained guidance.
-
Selection to present Phase 1 UNO solid tumor data at AACR 2026 meeting.
-
Announcement of participation in two early‑February healthcare investor conferences.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GARDEN CITY, N.Y., March 11, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that Steve Lisi, Chairman & Chief Executive Officer of Beyond Air, will participate in the 38th Annual Roth Conference being held March 22nd to 24th in Laguna Niguel, CA.
| 38th Annual Roth Conference | |
| Format: | Fireside chat and one-on-one meetings |
| Presentation Date: | Monday, March 23 at 8:00am PT |
| Participant: | Steve Lisi, Chairman & Chief Executive Officer of Beyond Air |
| Live Webcast Link: | https://event.summitcast.com/view/kKmFFrbEes9oUCyrRFmQ5N/guest_book?session_id=LxtopFpYTZL68pJiouzW2f |
If you are interested in requesting a one-on-one meeting at the conference, please contact your bank representative to schedule accordingly.
An archive of the webcast will be available at https://www.beyondair.net/news-events/events for 90 days following the event.
About Beyond Air®, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. Beyond Air is currently advancing its other revolutionary LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria (NTM).
Additionally, Beyond Cancer, Ltd., an affiliate of Beyond Air, is investigating ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting. For more information, visit www.beyondair.net.
CONTACTS:
Investor Relations contacts
Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.